(Q44673043)

5 December 2017

title

Piribedil as an adjunct to levodopa in advanced Parkinson's disease: the Asian experience (English)

1 reference

5 December 2017

1 reference

1 reference

Virgilio Gerald H Evidente

1

1 reference

5 December 2017

Raymund P Esteban

2

1 reference

5 December 2017

Francis M Domingo

3

1 reference

5 December 2017

Lourdjean O Carbajal

4

1 reference

5 December 2017

Mercedita A Parazo

5

1 reference

5 December 2017

publication date

1 December 2003

1 reference

5 December 2017

number of pages

5

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

5 December 2017

volume

10

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

117-121

1 reference

Evidence for a new type of dopamine receptor stimulating agent.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900096-8

7 January 2021

Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmoset

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900096-8

7 January 2021

Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900096-8

7 January 2021

What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900096-8

7 January 2021

Adjuncts to levodopa therapy: dopamine agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900096-8

7 January 2021

Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900096-8

7 January 2021

Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900096-8

7 January 2021

Sleep attacks in patients taking dopamine agonists: review

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900096-8

7 January 2021

Piribedil and bromocriptine in Parkinson's disease: a single-blind crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900096-8

7 January 2021

Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900096-8

7 January 2021

Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900096-8

7 January 2021

Effects of a dopamine agonist piribedil in depressed patients: relationship of pretreatment homovanillic acid to antidepressant response

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2803%2900096-8

7 January 2021

10.1016/S1353-8020(03)00096-8

Identifiers

DOI

1 reference

5 December 2017

1 reference